Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Afaq Sarwar who wrote (2577)	1/12/1998 6:51:00 PM
From: Gabor	Respond to of 3906

If the patent is approved,than why don't they produce a product?You can't make any money if you have nothing to sell.

To: Afaq Sarwar who wrote (2577)	1/12/1998 7:10:00 PM
From: don roberson	Read Replies (1) \| Respond to of 3906

Afaq: This is very good news. Not going to get excited. Not yet.

To: Afaq Sarwar who wrote (2577)	1/13/1998 2:41:00 PM
From: Gary Korn	Read Replies (2) \| Respond to of 3906

Their US patent that has already been approved also covers both the drug and the delivery system. So in this case the assumption turned out to be correct. Afaq, If there were a U.S. patent, there would be a U.S. patent number and it would be searchable on the IBM patent office search engine. Either I'm missing something, or no one on this thread to this date has found a U.S. patent number for HVSF or anything thru the IBM search engine. Next time you speak to HVSF mgmt., perhaps you might get them to divulge this important piece of information, if it exists. (When I have an opportunity, I certainly plan to call HVSF on this...I should have done so long ago.) Gary Korn